CONMED (CNMD) vs Lumexa Imaging (LMRI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
CONMED is the larger company by market cap ($1.33 billion vs $1.01 billion), about 1.3 times the size. On valuation, CONMED trades at a lower forward P/E (9.3x vs 11.8x for Lumexa Imaging). CONMED pays a dividend yielding 0.45%, while Lumexa Imaging does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CNMD | LMRI |
|---|---|---|
| Share price | $44.42 | $10.54 |
| Market cap | $1.33B | $1.01B |
| 1-day change | -1.53% | +2.03% |
| YTD return | +9.41% | -43.03% |
| 1-year return | -2.18% | — |
| 5-year return | -68.72% | — |
| P/E ratio (TTM) | 24.01 | — |
| Forward P/E | 9.29 | 11.84 |
| EPS (TTM) | $1.85 | $-0.37 |
| Dividend yield | 0.45% | 0.00% |
| Annual dividend | $0.20 | $0.00 |
| Revenue (latest FY) | $1.37B | — |
| Revenue growth (YoY) | +5.18% | — |
| Net income (latest FY) | $47.05M | — |
| Gross margin | 54.59% | — |
| Operating margin | 7.46% | — |
| Net margin | 3.42% | — |
| 52-week high | $53.66 | $19.45 |
| 52-week low | $31.44 | $6.45 |
| Distance from 52-week high | -17.22% | -45.81% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +2.43% | +67.65% |
| Average volume | 482.58K | 430.76K |
| Shares outstanding | 29.95M | 96.07M |
| Employees | 3,900 | 5,000 |
| Sector | Healthcare | Health Care |
| Industry | Medical Devices | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- The two companies sit in different sectors: CONMED in Healthcare and Lumexa Imaging in Health Care.
About CONMED
CNMD stock →CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as powered resection instruments, fluid management and visualization systems, and related single-use products that enable surgeons to perform minimally invasive sports medicine surgeries.
Healthcare · Medical Devices · 3,900 employees
About Lumexa Imaging
LMRI stock →Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States.
Health Care · Medical Specialities · 5,000 employees
CNMD vs LMRI FAQ
Which is bigger, CONMED or Lumexa Imaging?
CONMED (CNMD) is larger, with a market capitalization of $1.33B compared with $1.01B for Lumexa Imaging (LMRI).
Which pays a higher dividend, CONMED or Lumexa Imaging?
CONMED pays a dividend yielding 0.45%, while Lumexa Imaging does not currently pay a regular dividend.
Are CONMED and Lumexa Imaging in the same industry?
No. CONMED is in the Healthcare sector, while Lumexa Imaging is in Health Care.